The present invention relates to EP4 agonist bisphosphonate conjugates or related compounds and uses thereof. Said conjugates or related compounds may be used to provide delivery of an EP4 agonist or related compound to a desired site of action such as a bone. Bisphosphonate moieties linked to the EP4 agonists via amide linkers have been implicated in the inhibition of bone resorption and bone targeting.